Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Oct 31;16(5):2499-2501.
doi: 10.21037/jgo-2025-630. Epub 2025 Oct 15.

Investigating survival patterns in pancreatic adenocarcinoma over two decades after introducing FOLFIRINOX

Jessica Döbereiner  1 , Jörg Kleeff  1 , Artur Rebelo  1
Affiliations
Editorial

Investigating survival patterns in pancreatic adenocarcinoma over two decades after introducing FOLFIRINOX

Jessica Döbereiner et al. J Gastrointest Oncol. .
No abstract available

Keywords: FOLFIRINOX; Pancreatic adenocarcinoma (PDAC); chemotherapy; pancreatic cancer; survival patterns.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jgo.amegroups.com/article/view/10.21037/jgo-2025-630/coif). The authors have no conflicts of interest to declare.

Comment on

References

    1. Felismino TC, Rodrigues D, Brito A, et al. Evolving survival patterns in pancreatic adenocarcinoma: a 23-year retrospective observational analysis. J Gastrointest Oncol 2025;16:1280-6. 10.21037/jgo-2024-942 - DOI - PMC - PubMed
    1. Stoffel EM, Brand RE, Goggins M. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. Gastroenterology 2023;164:752-65. 10.1053/j.gastro.2023.02.012 - DOI - PMC - PubMed
    1. Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin 2024;74:12-49. 10.3322/caac.21820 - DOI - PubMed
    1. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011;364:1817-25. 10.1056/NEJMoa1011923 - DOI - PubMed
    1. Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med 2013;369:1691-703. 10.1056/NEJMoa1304369 - DOI - PMC - PubMed

LinkOut - more resources